Please provide your email address to receive an email when new articles are posted on . A 54-year-old man was referred in late 2014 for a consultation for corneal transplant surgery in the left eye.

Please provide your email address to receive an email when new articles are posted on . BOSTON — Annual exams with topography are key to identifying progression in patients with keratoconus regardless ...

Credit: Glaukos. Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.

SHERBORN, Mass.--(BUSINESS WIRE)--CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today published results of the EpiSmart cross-linking Phase ...

On Monday, Glaukos Corporation (NYSE:GKOS) received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) acknowledging the previously submitted New Drug Application (NDA) for ...

(MASS APPEAL) – If you’ve been diagnosed with Keratoconus then Corneal Cross Linking might get you back to better eyesight. Mass Appeal’s Patrick Berry joined Dr. John P. Frangie, MD to learn more.

A Clarenville man is asking the province to pay for surgery to keep him from losing his vision to a rare eye disease. Wyatt Ellis says he needs cornea cross-linking surgery but Newfoundland and ...

For most of his young life, the 15-year-old Wyoming High School sophomore ran into things, struggled with activities he enjoyed like catching a baseball and even found himself missing the other hand ...

An artificial intelligence (AI) algorithm may allow clinicians to predict risk of keratoconus progression with more than 90% accuracy, according to a retrospective study. Using data from the second ...